Video coaching intervention for mothers using opioids
A Scaleable Video Coaching Intervention for Opioid-using Mothers
This study tests whether video coaching can help mothers in treatment for opioid misuse become better parents and improve their well-being and their children's development.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 180 (estimated) |
| Ages | N/A to 50 Years |
| Sex | All |
| Sponsor | University of Oregon Academic / other |
| Locations | 1 site (Eugene, Oregon) |
| Trial ID | NCT04749771 on ClinicalTrials.gov |
What this trial studies
This study evaluates a novel parenting intervention that uses video coaching to enhance responsive parenting among mothers who are in treatment for opioid misuse. It involves a randomized trial with opioid-using women and their children aged 0-36 months, assessing the impact of the intervention on caregiver recovery, psychological well-being, and child development. The study aims to understand how improvements in caregiving can mediate recovery from addiction and improve child outcomes through changes in caregiver functioning and self-concept.
Who should consider this trial
Good fit: Ideal candidates are adult women aged 18-50 who are biological parents of children aged 0-48 months and are currently receiving treatment for a substance use disorder.
Not a fit: Patients who are pregnant, have certain medical conditions, or do not meet the age and treatment criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve parenting skills and recovery outcomes for mothers struggling with opioid addiction, benefiting both the mothers and their children.
How similar studies have performed: Other studies have shown promise in using video coaching for parenting interventions, suggesting potential success for this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Must be an adult (18-50 years of age) * Must be the biological parent of a child between the ages of 0-48 months of age * Must have received, or be currently receiving, treatment for a substance use disorder for any DSM-5 class of substance use disorder except caffeine or tobacco. This includes alcohol, cannabis, hallucinogens, inhalants, opioids, sedatives, hypnotics/anxiolytics, and stimulants. * Must have their child at least two days each week at study entry Exclusion Criteria: * Metal implants, metal fragments, pacemakers, or other electronic medical implants * Claustrophobic * Weigh \> 550 lbs * Women who are or think they may be pregnant * History of neurological disorders * Left-handed
Where this trial is running
Eugene, Oregon
- University of Oregon — Eugene, Oregon, United States (Recruiting)
Study contacts
- Principal investigator: Philip A Fisher, Ph.D. — University of Oregon
- Study coordinator: Alexander S Wagnon, B.S.
- Email: awagnon@uoregon.edu
- Phone: 541-346-8064
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.